BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-612@pharmaconomics
DTSTAMP:20260707T034629Z
DTSTART;VALUE=DATE:20280630
DTEND;VALUE=DATE:20280701
SUMMARY:MIRM Phase 3 — AZURE 2 & 3 (estimated date)
DESCRIPTION:Phase 3 trial results for AZURE 2 & 3 in Hepatitis Delta Virus are due ~ Jun 30\, 2028. A clean hit validates the program\; a miss can gap the stock down hard.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/1759425/000175942526000004/mirumupdatedcorporatepre.htm\n\nTrack it: https://www.pharmaconomics.com/e/612
URL:https://www.pharmaconomics.com/e/612
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:MIRM catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR